Real-World Evidence Solutions Global Market Report 2022: Need for Precise and Clear Information About the Safety and Efficacy of New Products Driving Adoption – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Real-World Evidence Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global real-world evidence solutions market size reached US$ 1.41 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 3.01 Billion by 2027, exhibiting a CAGR of 13.47% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Real-world evidence (RWE) refers to clinical evidence about the use and potential benefits or risks of medical products via real-world data (RWD). It can be produced via different study designs or analyses, including randomized trials, big simple trials, pragmatic trials, and observational studies.

It provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, and the balance between efficacy and safety. As it can also assist researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can help them design better pre-trial studies, there is a rise in the demand for RWE solutions around the world.

Real-World Evidence Solutions Market Trends:

The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market. Moreover, there is a rise in the demand for these solutions to detect varied reactions, product subpopulation effects, and product value when utilized by complex and comorbid patients. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Additionally, the growing utilization of advanced analytics and technological solutions in RWE for clinical development, commercialization, speed innovation, and accelerating improvements in healthcare outcomes is positively influencing the market.

Besides this, there are various initiatives undertaken by governments of several countries to promote the use of RWE solutions, which provide the efficacy of drugs and vaccines. This, coupled with a shift from volume to value-based care, is offering lucrative growth opportunities to industry investors.

Apart from this, the growing adoption of digitalization and patient-centered virtual care is catalyzing the demand for RWE solutions. Furthermore, there is an increase in the prevalence of chronic diseases, such as cancer, obesity, and diabetes, across the globe. In line with this, the rising delays in drug development and the subsequent increase in development costs are bolstering the growth of the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global real-world evidence solutions market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, therapeutic area and end user.

Breakup by Component:

• Clinical Settings Data
• Claims Data
• Patient-Powered Data
• Pharmacy Data
• Others

Breakup by Therapeutic Area:

• Oncology
• Immunology
• Neurology
• Cardiovascular Disease
• Others

Breakup by End User:

• Pharmaceutical and Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Key Questions Answered in This Report:

• How has the global real-world evidence solutions market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global real-world evidence solutions market?
• What are the key regional markets?
• What is the breakup of the market based on the component?
• What is the breakup of the market based on the therapeutic area?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global real-world evidence solutions market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Real-World Evidence Solutions Market

6 Market Breakup by Component

7 Market Breakup by Therapeutic Area

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

Companies Mentioned

• Aetion Inc.
• Clinigen Limited
• Flatiron Health Inc. (Roche Holding AG)
• ICON plc
• International Business Machines Corporation
• IQVIA
• Optum Inc. (UnitedHealth Group Incorporated)
• Oracle Corporation
• Parexel International Corporation
• PPD Inc. (Thermo Fisher Scientific Inc.)
• Sas Institute Inc.
• Syneos Health.

For more information about this report visit https://www.researchandmarkets.com/r/57ewbv

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900